Garabet Yeretssian

Garabet Yeretssian, PhD is an experienced executive and scientific leader in the non-profit, biotech and academic space. Currently, Dr. Yeretssian is a Science Program Manager at the Chan Zuckerberg Initiative, where he is responsible for managing initiatives related to inflammation and rare pediatric inflammatory diseases. Previously, he has worked as the Director for the Helmsley Charitable Trust’s Crohn’s Disease Program, where he was responsible for providing the visionary leadership for a multimillion-dollar scientific and clinical portfolio, defining a long-term vision and establishing a strategy for the Crohn’s Disease Program. Prior to joining Helmsley, Dr. Yeretssian was an assistant professor in the Immunology and Tisch Cancer Institutes at the Icahn School of Medicine at Mount Sinai where he led a research team investigating the implication of innate immune and cell death mechanisms in Inflammatory Bowel Diseases, colorectal cancer and other gastrointestinal disorders.